Orbit Genomics
Boulder
About Orbit Genomics
Orbit Genomics technology platform enables early disease detection, treatment, and prevention of complex diseases. The platform analyzes repetitive DNA which uniquely reflects both inherited and acquired disease risk. They provides technology platform analyzes a different part of your DNA that uniquely reflects both inherited predisposition to disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Feb 2024)
- Website: orbitgenomics.com
- Phone: 720-515-0395
Industries & Categories
Health Care, Health Diagnostics, Hospital
Social Profiles
Canonical: https://fsome.com/organization/orbit-genomics-118828 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.